Respiratory Inhalers Market
Market Overview
Respiratory inhalers are used with complementary spacer or holding chamber device, in order to reduce the accumulation in the throat and mouth and to handle the need for precise synchronization of the start of inhalation with actuation of the device.
Statistics:
The globalย Respiratory Inhaler Marketย is estimated to account for US$ 32,921.8 Mn in terms of value and is expected to reach US$ 46,984.1 Mn by the end of 2027.
Drivers
Growing adoption of combination therapies including trial combination therapy for chronic obstructive pulmonary disease (COPD) is expected to propel the global respiratory inhalers market growth over the forecast period. Such therapies provide various diseases including more reliability in complex patients, increased efficacy, and easy reimbursement policies associated with the therapy.
Opportunities
Smart inhaler technology is a novel technology developed to help the patients in keeping a check on their doses and offers various other features. Some devices with smart inhaler technology are capable to read environment pollution, in terms of air quality, and it may alert the patient on presence of triggers of asthma in the air. Propeller Health, a U.S.-based company started supplementing medicines with this technology. They have connected an inhaler with Bluetooth transmitter to provide connectivity to the smartphone. This technology can keep a track of a patientโs frequency of suffering an asthmatic attack and causes behind the triggers and provide it to their respective healthcare professional.
๐๐จ ๐ ๐๐ญ ๐๐จ๐ซ๐ ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ @ https://www.coherentmarketinsights.com/insight/request-sample/227
Restraints
Lack of skilled physicians and pulmonologists are expected to hinder the global respiratory inhalers market growth over the forecast period.
Key Takeaways
The metered dose inhaler sub-segment in product type segment in the global Respiratory Inhaler Market was valued at US$ 22,360.9 Mn in 2018 and is expected to reach US$ 33,825.0 Mn by 2027 at a CAGR of 4.5% during the forecast period.
Metered-dose inhaler delivers specific dose of medication in aerosol form. The metered-dose inhaler was the first marketed inhaler in 1950s and is still the most common inhaler used across the globe. Moreover, its low cost compared to other advanced inhalers such as dry powder inhaler and nebulizer, gives it a competitive advantage, especially in developing economies inducing India, China, and Brazil, where cost is one of the critical factors.
The manually operated inhaler devices sub segment in the technology segment held dominant position in the global Respiratory Inhaler Market in 2018, accounting forย 93.1%ย share in terms of value, followed by digitally operated inhaler devices.
Manual inhalers are the most common type of respiratory inhalers. In manual inhalers, medication is stored in pressurized canister in solution form, which also contains a propellant. The most common propellant used is hydrofluoroalkane (HFA), which is environment friendly.
The Asthma sub segment in disease indication segment held dominant position in the global Respiratory Inhaler Market in 2018, accounting forย 60.4%ย share in terms of value, followed by COPD and pulmonary arterial hypertension, respectively.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐ @ https://www.coherentmarketinsights.com/promo/buynow/227
Product launches for the treatment of asthma is expected to support growth of the market over the forecast period. For instance, In January 2017, U.S. FDA approved AstraZenecaโs Symbicort (budesonide/formoterol fumarate dihydrate), a metered-dose inhaler for the treatment of asthma in pediatric patients aged six to 12 years.
Market Trends
Rising R&D activities related to proper use of inhaler device is expected to propel the market growth. For instance, in September 2018, researchers from University of Helsinki, Finland, reported investigation of non-verbal, demonstrational videos as a method of teaching inhaler naรฏve individuals how to use a dry powder inhaler (DPI).
The market is also witnessing launch of devices to track usage pattern of metered-dose inhalers (MDI). For instance, in November 2019, Lupin Ltd. launched a device โ Adhero โ to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases.
Competitive Section
Key companies involved in the global respiratory inhalers market are AstraZeneca plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding, and Teva Pharmaceutical Industries Ltd.
Key Developments
Key players in the market are focused on launching smart inhaler devices to expand their product portfolio. For instance, in January 2019, FindAir, a European company developing digital systems for asthma and COPD control, launched its commercial smart inhaler device FindAir ONE
Key players in the market are also focused on receiving certification from regulatory bodies for their novel inhaler devices. For instance, in September 2019, Novartis International AGโs Concept1 inhaler received certification under the new EU Medical Devices Regulation (MDR).
๐๐๐ญ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ: (๐๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐, ๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐๐ฅ๐๐ฌ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ก๐๐ซ๐ญ) @ https://www.coherentmarketinsights.com/insight/request-pdf/227
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Disease Indication
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
- Market Dynamics
- Global Respiratory Inhaler Market, By Product Type, 2017 โ 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019โ2027
- Segment Trends
- Dry Powder Inhaler
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Metered Dose Inhaler
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Nebulizer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Ultrasonic Nebulizer
- Compressed Air Nebulizer
- Mesh Nebulizer
- Introduction
- Global Respiratory Inhaler Market, By Technology, 2017 โ 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019โ2027
- Segment Trends
- Manually Operated Inhaler Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Digitally Operated Inhaler Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Introduction
- Global Respiratory Inhaler Market, By Disease Indication, 2017 โ 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019โ2027
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/respiratory-inhalers-market-to-surge-past-us-448-billion-by-2025-197
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837